DrugCite
Search

TAXOTERE

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Taxotere Adverse Events Reported to the FDA Over Time

How are Taxotere adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Taxotere, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Taxotere is flagged as the suspect drug causing the adverse event.

Most Common Taxotere Adverse Events Reported to the FDA

What are the most common Taxotere adverse events reported to the FDA?

Dyspnoea
696 (2.09%)
Diarrhoea
645 (1.94%)
Pyrexia
580 (1.74%)
Nausea
521 (1.56%)
Interstitial Lung Disease
499 (1.5%)
Vomiting
466 (1.4%)
Febrile Neutropenia
459 (1.38%)
Neutropenia
456 (1.37%)
Dehydration
448 (1.35%)
White Blood Cell Count Decreased
350 (1.05%)
Asthenia
325 (.98%)
Show More Show More
Pneumonia
311 (.93%)
Hypotension
306 (.92%)
Fatigue
301 (.9%)
Abdominal Pain
289 (.87%)
Haemoglobin Decreased
281 (.84%)
Pleural Effusion
246 (.74%)
Anaemia
243 (.73%)
Respiratory Failure
238 (.71%)
Death
236 (.71%)
Sepsis
232 (.7%)
Neutrophil Count Decreased
221 (.66%)
Mucosal Inflammation
204 (.61%)
Pain
182 (.55%)
Renal Failure Acute
181 (.54%)
Renal Failure
179 (.54%)
Oedema Peripheral
178 (.53%)
Hypokalaemia
176 (.53%)
Erythema
170 (.51%)
Pulmonary Embolism
167 (.5%)
Chest Pain
161 (.48%)
Dizziness
161 (.48%)
General Physical Health Deteriorati...
159 (.48%)
Disease Progression
154 (.46%)
Stomatitis
154 (.46%)
Cough
152 (.46%)
Hyponatraemia
150 (.45%)
Back Pain
145 (.44%)
Platelet Count Decreased
144 (.43%)
Leukopenia
143 (.43%)
Malaise
140 (.42%)
Disseminated Intravascular Coagulat...
138 (.41%)
Decreased Appetite
133 (.4%)
Blood Creatinine Increased
132 (.4%)
Oedema
131 (.39%)
Rash
130 (.39%)
Alopecia
129 (.39%)
Cardiac Arrest
128 (.38%)
Hypoxia
128 (.38%)
Anorexia
126 (.38%)
Flushing
126 (.38%)
Loss Of Consciousness
124 (.37%)
Septic Shock
124 (.37%)
Chills
119 (.36%)
Palmar-plantar Erythrodysaesthesia ...
117 (.35%)
Blood Pressure Decreased
114 (.34%)
Pneumonitis
113 (.34%)
Atrial Fibrillation
112 (.34%)
Myalgia
112 (.34%)
Haematocrit Decreased
111 (.33%)
Acute Respiratory Distress Syndrome
109 (.33%)
Constipation
107 (.32%)
Weight Decreased
106 (.32%)
Confusional State
103 (.31%)
Aspartate Aminotransferase Increase...
102 (.31%)
Pancytopenia
102 (.31%)
Thrombocytopenia
101 (.3%)
Malignant Neoplasm Progression
100 (.3%)
Multi-organ Failure
100 (.3%)
Infusion Related Reaction
98 (.29%)
Tachycardia
95 (.29%)
Arthralgia
94 (.28%)
Chest Discomfort
94 (.28%)
Cardiac Failure
93 (.28%)
Oxygen Saturation Decreased
92 (.28%)
Neuropathy Peripheral
91 (.27%)
Alanine Aminotransferase Increased
90 (.27%)
Blood Lactate Dehydrogenase Increas...
90 (.27%)
Urinary Tract Infection
90 (.27%)
Syncope
89 (.27%)
Bone Marrow Failure
87 (.26%)
White Blood Cell Count Increased
85 (.26%)
Fall
84 (.25%)
Heart Rate Increased
84 (.25%)
Ascites
83 (.25%)
Hypersensitivity
83 (.25%)
Condition Aggravated
81 (.24%)
Shock
81 (.24%)
Blood Glucose Increased
80 (.24%)
Dysphagia
80 (.24%)
Pulmonary Oedema
76 (.23%)
Blood Urea Increased
75 (.23%)
Blood Alkaline Phosphatase Increase...
73 (.22%)
Lung Infiltration
72 (.22%)
Colitis
71 (.21%)
Osteonecrosis
70 (.21%)
Paraesthesia
70 (.21%)
Blood Sodium Decreased
69 (.21%)
Hyperhidrosis
69 (.21%)
Hypoaesthesia
69 (.21%)
Cardiac Failure Congestive
66 (.2%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Taxotere, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Taxotere is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Taxotere

What are the most common Taxotere adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Taxotere, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Taxotere is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Taxotere According to Those Reporting Adverse Events

Why are people taking Taxotere, according to those reporting adverse events to the FDA?

Breast Cancer
1921
Prostate Cancer
706
Non-small Cell Lung Cancer
600
Breast Cancer Metastatic
369
Drug Use For Unknown Indication
200
Lung Neoplasm Malignant
172
Show More Show More
Prostate Cancer Metastatic
145
Ovarian Cancer
136
Gastric Cancer
134
Oesophageal Carcinoma
120
Neoplasm Malignant
104
Chemotherapy
101
Head And Neck Cancer
90
Squamous Cell Carcinoma
88
Product Used For Unknown Indication
48
Metastases To Bone
46
Lung Cancer Metastatic
45
Pancreatic Carcinoma
43
Breast Cancer Recurrent
42
Lung Adenocarcinoma
41
Prostate Cancer Stage Iv
36
Sarcoma
36
Hypopharyngeal Cancer
34
Breast Cancer Female
34
Uterine Cancer
32
Non-small Cell Lung Cancer Metastat...
26
Laryngeal Cancer
25
Bladder Cancer
25
Bronchial Carcinoma
23
Pancreatic Carcinoma Metastatic
23
Metastatic Gastric Cancer
23
Adenocarcinoma
22
Lung Adenocarcinoma Stage Iv
22
Non-small Cell Lung Cancer Recurren...
21
Oesophageal Adenocarcinoma
21
Lung Squamous Cell Carcinoma Stage ...
20
Carcinoma
19
Prostate Cancer Recurrent
19
Metastasis
19
Tongue Neoplasm Malignant Stage Uns...
18
Metastases To Lung
17
Breast Cancer Stage Ii
16
Non-small Cell Lung Cancer Stage Iv
16
Nasopharyngeal Cancer
16
Metastases To Liver
16
Ureteric Cancer Metastatic
16
Breast Cancer Stage Iv
15
Transitional Cell Carcinoma
15
Neoplasm Recurrence
14
Metastatic Neoplasm
13
Endometrial Cancer
12

Drug Labels

LabelLabelerEffective
Taxoteresanofi-aventis U.S. LLC13-DEC-11
Taxoteresanofi-aventis U.S. LLC05-JAN-12

Taxotere Case Reports

What Taxotere safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Taxotere. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Taxotere.